SCHEMBL5665462

SCHEMBL5665462

O=C(OC(Br)C(OCc1ccccc1)OCc1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A3 Q01959 1/20 0.53
TSHR P16473 2/20 0.50
TP53 P04637 1/20 0.50
CYP2D6 P10635 2/20 0.47
SLC1A3 P43003 2/20 0.46
SLC1A2 P43004 2/20 0.46
SLC1A1 P43005 2/20 0.46
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 4/20 0.45
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
ESR1 P03372 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5664138 0.83 TSHR (0.47) KMT2ATDP1TSHRTP53CYP2D6
SCHEMBL5665484 0.81 KMT2A (0.53) KMT2ATDP1SLC6A2SLC6A3TSHR
SCHEMBL21451175 0.79 TP53 (0.71) KMT2ATDP1SLC6A2SLC6A3TSHR
SCHEMBL26036566 0.79 TP53 (0.71) KMT2ATDP1SLC6A2SLC6A3TSHR
SCHEMBL27777630 0.78 KMT2A (0.56) KMT2ATDP1SLC6A2SLC6A3TSHR
SCHEMBL5664140 0.77 TSHR (0.52) KMT2ATDP1SLC6A3TSHRTP53
SCHEMBL5663593 0.77 KMT2A (0.47) KMT2ATDP1SLC6A2SLC6A3TSHR
SCHEMBL1446741 0.74 KMT2A (0.51) KMT2ATDP1SLC6A2SLC6A3TSHR
SCHEMBL5806046 0.73 KMT2A (0.50) KMT2ATDP1SLC6A2SLC6A3CYP2D6
SCHEMBL3156023 0.73 KMT2A (0.50) KMT2ATDP1SLC6A2SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1461041-A4 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD (BB) 2006-03-29 EP claimed
EP-1461041-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES Pharmasset Ltd. (BB) 2004-09-29 EP claimed
WO-2003051298-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD. (BB) 2003-06-26 WO claimed